1.
|
Adriblastin RD
|
Trockensub 10 mg c solv
|
Durchstf 1 Stk
|
14.60
|
32.10
|
01.12.2023
|
|
|
|
Nein
|
50357015
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15691
|
15.03.1991
|
|
|
|
|
07.16.10.
|
L01DB01
|
2.
|
Adriblastin RD
|
Trockensub 50 mg c Solv
|
Durchstf 1 Stk
|
73.00
|
94.70
|
01.12.2023
|
|
|
|
Nein
|
50357001
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15691
|
01.07.2022
|
|
|
|
|
07.16.10.
|
L01DB01
|
3.
|
Adriblastin Sol
|
Inj Lös 10 mg/5ml
|
Cytosafe 5 ml
|
12.60
|
30.05
|
01.12.2021
|
|
|
|
Nein
|
50358054
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15876
|
01.04.2002
|
|
|
|
O
|
07.16.10.
|
L01DB01
|
4.
|
Adriblastin Sol
|
Inj Lös 20 mg/10ml
|
Cytosafe 10 ml
|
33.03
|
52.35
|
01.01.2011
|
|
|
|
Nein
|
50358062
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15876
|
01.04.2002
|
|
|
|
O
|
07.16.10.
|
L01DB01
|
5.
|
Adriblastin Sol
|
Inj Lös 50 mg/25ml
|
2 Cytosafe 25 ml
|
122.97
|
150.15
|
01.12.2022
|
|
|
|
Nein
|
50358070
|
Pfizer AG
|
Doxorubicini hydrochloridum
|
15876
|
01.04.2002
|
|
|
|
O
|
07.16.10.
|
L01DB01
|
6.
|
Caelyx
|
Inf Konz 20 mg/10ml
|
Amp 10 ml
|
232.38
|
269.15
|
01.12.2023
|
|
|
L
|
Nein
|
54273010
|
Baxter AG
|
Doxorubicini hydrochloridum, PEG liposomal
|
16985
|
15.03.1999
|
|
|
|
|
07.16.10.
|
L01DB01
|
7.
|
Doxorubicin Sandoz eco
|
Inj Lös 10 mg/5ml
|
5 ml
|
11.06
|
28.50
|
01.12.2023
|
|
|
|
Nein
|
54828001
|
Sandoz Pharmaceuticals AG
|
Doxorubicini hydrochloridum
|
20228
|
01.05.2014
|
|
|
|
G
|
07.16.10.
|
L01DB01
|
8.
|
Doxorubicin Sandoz eco
|
Inj Lös 50 mg/25ml
|
25 ml
|
55.30
|
76.55
|
01.12.2023
|
|
|
|
Nein
|
54828002
|
Sandoz Pharmaceuticals AG
|
Doxorubicini hydrochloridum
|
20228
|
01.05.2014
|
|
|
|
G
|
07.16.10.
|
L01DB01
|
9.
|
Doxorubicin Sandoz eco
|
Inj Lös 100 mg/50ml
|
50 ml
|
110.60
|
136.70
|
01.12.2023
|
|
|
|
Nein
|
54828003
|
Sandoz Pharmaceuticals AG
|
Doxorubicini hydrochloridum
|
20228
|
01.05.2014
|
|
|
|
G
|
07.16.10.
|
L01DB01
|
10.
|
Doxorubicin Sandoz eco
|
Inj Lös 200 mg/100ml
|
100 ml
|
221.20
|
257.00
|
01.12.2023
|
|
|
L
|
Nein
|
54828004
|
Sandoz Pharmaceuticals AG
|
Doxorubicini hydrochloridum
|
20228
|
01.07.2020
|
|
|
|
G
|
07.16.10.
|
L01DB01
|